A Member of the University of Maryland Medical System | In Partnership with the University of Maryland School of Medicine
Parkinsonismo de tipo secundario
El tratamiento de las afecciones que pueden causar el parkinsonismo secundario puede disminuir el riesgo.
Utilice únicamente medicamentos bajo la supervisión de un médico. Se debe vigilar a las personas con afecciones, como la esquizofrenia, que requieran el uso prolongado de antipsicóticos para evitar el desarrollo de parkinsonismo secundario. Los medicamentos antipsicóticos más nuevos tienen menos probabilidad de causar parkinsonismo secundario.
Lang A. Parkinsonism. In: Goldman L, Ausiello D. Cecil Textbook of Medicine. 23rd ed. Philadelphia, Pa: Saunders Elsevier;2007:chap 433.
Lang AE. When and how should treatment be started in Parkinson disease? Neurology. 2009;72(7 Suppl):S39-43.
Lewitt PA. Levodopa for the treatment of Parkinson's disease. N Engl J Med. 2008;359(23):2468-76.
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorous standards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. is also a founding member of Hi-Ethics and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).
© 2011 University of Maryland Medical Center (UMMC). All rights reserved.
UMMC is a member of the University of Maryland Medical System,
22 S. Greene Street, Baltimore, MD 21201. TDD: 1-800-735-2258 or 1.866.408.6885